Publications by authors named "Craig Bennison"

Claim this Profile
C
Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective.
Takao Takeshima, Fumihiko Sakai, Xinyu Wang, Kentaro Yamato, Yoshitsugu Kojima, Craig Bennison

Pharmacoeconomics· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes of Eladocagene Exuparvovec Compared with Standard of Care in Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Modelling Study.
Claire L Simons, Wuh-Liang Hwu, Rongrong Zhang, Martijn J H G Simons, Mats Bergkvist, Craig Bennison

Adv Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Monthly Migraine-Day Distributions Using Longitudinal Regression Models and Linking Quality of Life to Inform Cost-Effectiveness Analysis: A Case Study of Fremanezumab in Japanese-Korean Migraine Patients.
Xinyu Wang, Kentaro Yamato, Yoshitsugu Kojima, Josef J Paris, Elisabeth F P Peterse, Craig Bennison

Pharmacoeconomics· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Comment on "An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia".
Marjanne A Piena, Natalie Houwing, Carla W Kraan, Xiaofeng Wang, Heidi Waters, Craig Bennison

Pharmacoeconomics· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland.
Michaela Barbier, Nicholas Durno, Craig Bennison, Mathias Örtli, Christian Knapp

Eur J Health Econ· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of KTE-X19 CAR T therapy versus real-world standard of care in patients with relapsed/refractory mantle cell lymphoma post BTKi in England.
Svenja Petersohn, Gilles Salles, Michael Wang, Jim Wu, Sally W Wade, Craig Bennison

J Med Econ· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia.
Marjanne A Piena, Natalie Houwing, Carla W Kraan, Xiaofeng Wang, Heidi Waters, Craig Bennison

Pharmacoeconomics· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States.
Claire L Simons, Daniel Malone, Michael Wang, Gregory A Maglinte, Tim Inocencio, Craig Bennison

J Med Econ· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health State Utilities of Patients with Heart Failure: A Systematic Literature Review.
Gian Luca Di Tanna, Michael Urbich, Heidi S Wirtz, Barbara Potrata, Marieke Heisen, Craig Bennison

Pharmacoeconomics· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014-2020).
Michael Urbich, Gary Globe, Krystallia Pantiri, Marieke Heisen, Craig Bennison

Pharmacoeconomics· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of ocriplasmin versus watchful waiting for treatment of symptomatic vitreomacular adhesion in the US.
Arshad M Khanani, Pravin U Dugel, Julia A Haller, Alan L Wagner, Benedicte Lescrauwaet, Craig Bennison

J Comp Eff Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies.
Joao Carrasco, Georg-Alexander Pietsch, Marie-Pierre Nicolas, Cecile Koerber, Craig Bennison

Adv Ther· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an Initial Conceptual Model of Multiple Myeloma to Support Clinical and Health Economics Decision Making.
Sebastian Gonzalez-McQuire, Meletios-Athanassios Dimopoulos, Katja Weisel, Walter Bouwmeester, Roman Hájek, Craig Bennison

MDM Policy Pract· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole.
Craig Bennison, Stephanie Stephens, Benedicte Lescrauwaet, Ben Van Hout, Timothy L Jackson

J Mark Access Health Policy· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis